UBS raises price targets on Molina Health and AppFolio, keeps Neutral ratings
UBS lifted its price target on Molina Health to $225 from $202 and on AppFolio to $240 from $220, leaving both stocks rated Neutral.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
UBS raised its price target on Molina Health (MOH) to $225 per share from $202, while keeping its Neutral rating. Dow Jones Newswires reported the change, citing ratings data from Benzinga.
UBS also lifted its target on AppFolio (APPF) to $240 from $220, and the Neutral rating on that company stayed unchanged. The moves concern price targets only, and the bank did not revise its ratings.
why it matters
Price target revisions usually reflect an update to valuation models and rarely move the broader market. For investors in these stocks, company earnings and guidance remain the main reference points.
tags
instruments
sources
- Molina Health Is Maintained at Neutral by UBS — Dow Jones Newswires, 23 October 2026 at 19:47 UTC
- AppFolio Is Maintained at Neutral by UBS — Dow Jones Newswires, 23 October 2026 at 19:54 UTC
- Blackstone Is Maintained at Neutral by UBS — Dow Jones Newswires, 23 October 2026 at 20:04 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗